retatrutide clinical trial results 2024 VisualAbstract: reduces body weight by 17.5% in patients with obesity New clinical trial results show

Role of prohormone convertases in the tissue-specific processing of proglucagon

Repeated stimulation of growth-hormone pathways may shift endocrine set points over months to years with unpredictable downstream consequences

Theres also a catalog of recipes on hand to inspire GLP-1-friendly meals

The treatment mimics a hormone called glucagon-like peptide 1 (GLP1), which stimulates your pancreas to produce more insulin

GLP-1 (Glucagon-Like Peptide-1) Receptor GIP (Glucose-Dependent Insulinotropic Polypeptide) Receptor Glucagon Receptor You can think of your weight management system as a fancy security system with three locks on it

Where the Side Effect Profiles Differ While the overall GI side effect rates are comparable, a 2025 comparative safety analysis noted some differences: semaglutide was associated with slightly higher rates of vomiting, constipation, and gastroesophageal reflux (GERD), while tirzepatide showed marginally higher rates of nausea at the highest dose levels